- Grants since 2016
- 239
- Awarded, last 5 years (where amounts are published)
- 34M
- Funded works, last 5 years
- 2 662
- Funded works, all time
- 7 142
Grants
2026–2028 · award
A Pilot Study of Early PET and Biomarker Dynamics in Patients with Stage 2 and 3 Triple Negative Breast Cancer Treated with Neoadjuvant Response-Adapted Chemotherapy with Pembrolizumab (NeoADAPT)
Elizabeth Jaffee · Johns Hopkins University
2026–2027 · award
Biomarkers To Assess Response in Early Phase Breast Cancer Prevention Trials
Carol Fabian · University of Kansas Medical Center
2026–2027 · award
Genomic Profiling of the Estrogen Hormonal Pathway for Breast Cancer Prevention and Treatment
Benita Katzenellenbogen · University of Illinois Urbana-Champaign
2026–2027 · award
Factors Associated with Imminent Risk of Late Recurrence in Hormone Receptor Positive Breast Cancer
Pamela Goodwin · Mount Sinai Health System
2026–2027 · award
The role of Glutathione Peroxidase 2 in Breast Cancer Progression & Metastasis
Rachel Hazan · Albert Einstein College of Medicine
2026–2028 · award
Oncogene signaling and therapeutic resistance to antiestrogens in breast cancer
Carlos L. Arteaga · The University Of Texas Southwestern Medical Center (ut Southwestern)
2026–2028 · award
A Model Clinical/Translational Research Program for Breast Cancer Survivors: A Focus on Cognitive Function after Breast Cancer
Patricia Ganz · The Regents Of The University Of California, Los Angeles
2026–2028 · award
Identifying predictors of endocrine therapy toxicity and effective management strategies to improve quality of life for patients with breast cancer
Norah Henry · Regent University
2026–2028 · award
Novel potential drug targets for treatment of triple-negative breast cancer
Jenny Chang · Methodist Hospital
2026–2027 · award
A ctDNA screening program in patients with HR+, HER2 low metastatic breast cancer for detection of high-risk relapse patients on any CDK4/6 inhibitor followed by a single arm phase II trial of trastuzumab-deruxtecan in patients with persistent ctDNA
Fabrice Andre · Institut Gustave Roussy
2026–2027 · award
Intrinsic Subtype and Immune Signatures of Response in CALGB 49907 (ALLIANCE): Standard Chemotherapy (CMF or AC) versus Capecitabine in Patients 65 and Older with Early-Stage Breast Cancer
Evanthia Galanis · Mayo Clinic
2026–2027 · award
Identification of surface proteins on endocrine therapy resistant breast cancer cells that can be exploited to develop targeted radiopharmaceuticals
Donald Mcdonnell · Duke University
2026–2027 · award
Targeting alphaB-Crystallin in Basal-like Breast Cancer
Vincent Cryns · University of Wisconsin System
2026–2027 · award
Targeting breast cancer stem cells
Michael Clarke · The Board Of Trustees Of The Leland Stanford Junior University
2026–2027 · award
MDM2, MDM4/X, and Mutant p53 Signaling in Breast Cancer Persistent Repair
Jill Bargonetti · Hunter College Of Cuny Jointly With Research Foundation Of Cuny
2026–2027 · award
Molecular characterization of circulating tumor cells in various body liquids from patients with metastatic breast cancer
Christine Desmedt · KU Leuven
2026–2027 · award
Enhancing immunogenicity in ER+/HER2- metastatic breast cancer
Komal Jhaveri · Memorial Sloan Kettering Cancer Center
2026–2027 · award
Defining context-specific biomarkers of immunotherapy benefit in TNBC (PY3-4)
Justin Balko · Vanderbilt University Medical Center
2026–2028 · award
Novel Therapeutic Vulnerabilities of ESR1 mutant tumors
Suzanne Fuqua · Baylor College of Medicine
2026–2028 · award
ctDNA Guided Care in Patients with Metastatic Breast Cancer
Nancy Lin · Dana-Farber Cancer Institute
2026–2027 · award
Role of Immune Disruption in Breast Cancer Progression
E Hwang · Duke University
2026–2028 · award
Novel Therapeutics and Biomarker Development in Breast Cancer
Hayley Mcdaid · Albert Einstein College of Medicine
2026–2027 · award
Inherited Predisposition to Breast Cancer among Underserved Women in Palestine and Israel: The Middle East Breast Cancer Study (MEBCS)
Ephrat Levy-Lahad · Shaare Zedek Medical Center
2026–2028 · award
INTERVENTIONS TO IMPROVE DELIVERY OF ADVANCED BREAST CANCER CARE
Dawn Hershman · The Trustees Of Columbia University In The City Of New York
2026–2028 · award
The role of stress induced catecholamine stimulation in progression of ER+ breast cancer
Marc Lippman · Georgetown University
2026–2027 · award
Targeting the DNA Damage Response in Breast Cancer
David Cortez · Vanderbilt University
2026–2027 · award
Epigenetic Regulation of Cancer Stem Cells: New Targets and Treatments for Resistant Breast Cancer
Kathy Albain · Loyola University Chicago
2026–2027 · award
Context-Aware Precision Oncology: Linking Ancestry, Environmental Imprinting, and Spatial Tumor Immune States in Breast Cancer
Melissa Davis · Morehouse School of Medicine
2026–2028 · award
Immune health and early detection assessment in individuals with BRCA1/2 pathogenic variants
Susan Domchek · University of Pennsylvania
2026–2028 · award
Novel Molecular Targets in Combination with Radiation Therapy in Breast Cancer
Bruce Haffty · Rutgers Sexual and Reproductive Health and Rights
2026–2027 · award
The New York Breast Cancer Study
Mary-Claire King · University of Washington
2026–2027 · award
Breast Cancer in Asian American Women
Scarlett Gomez · Regent University
2026–2027 · award
Next-Generation AI-Driven Multi-Modal Risk Assessment Models for Breast Cancer
Despina Kontos · Columbia University Irving Medical Center
2026–2027 · award
Enhancing the benefits of CDK inhibition in breast cancer
Shom Goel · The University of Melbourne
2026–2028 · award
The Role of Metadherin in Immune Evasion of Metastatic Breast Cancer
Yibin Kang · Princeton University
2026–2028 · award
Discovering genes that collaborate with mutant TP53 to drive breast cancer aggressiveness
Joshua Labaer · Arizona Board Of Regents For And On Behalf Of Arizona State University
2026–2028 · award
Preclinical Investigations into Next Generation Incretin Therapy for Preventing Obesity-Associated Breast Cancer
Stephen Hursting · University of North Carolina at Chapel Hill
2026–2028 · award
Clinical implications of molecular subtype and microenvironment
Lisa Carey · University of North Carolina at Chapel Hill
2026–2028 · award
Oncoshare: A Real-World Data Laboratory to Advance Breast Cancer Treatment
Allison Kurian · The Board Of Trustees Of The Leland Stanford Junior University
2026–2027 · award
Precision Immunotherapy and Microbiome in Breast Cancer
Roisin Connolly · National University of Ireland